GLP-1 use was compared to insulin/metformin or sodium-glucose cotransporter 2 (SGLT2) inhibitors in BC patients with T2D or glycated hemoglobin (HbA1c) 6.5% (T2D cohort), and to non-use in BC patients with obesity (obesity cohort)
Step 2 Review of Lab Results & Personalized Treatment Plan Once your labs are complete, youll meet with your doctor for a detailed review of: Your body composition results Your blood work, including hormone and metabolic markers affecting weight Diet, stress, sleep, and lifestyle factors contributing to weight gain or difficulty losing weight Youll receive: A clear medical explanation of what is causing or contributing to weight challenges A diagnosis and prognosis in plain language A discussion of whether tirzepatide, semaglutide, or an alternative treatment is the safest and most effective option for you A customized medical weight-loss plan tailored to your biology, including follow-up visits, blood testing, body composition analysis, dose strategy, and realistic expectations for your journey If you choose to move forward, youll enroll in a weight-loss membership that includes: Ongoing doctor and medical assistant visits and phone calls Ongoing blood testing Ongoing body composition monitoring Medical support throughout your weight-loss journey Medication costs are billed through our clinic so we can ensure consistent supply, quality, and correct dosing, using compounded versions of tirzepatide and semaglutide that allow flexible titration for optimal benefit and tolerance
Twelve mice were randomly divided into 4 groups and injected into the tail vein with PBS, Ru(II)-OH, NP2, and NP4 (2 mg Ru/kg) on the days 1, 4, and 7
Retrieved from Kalra, S., & Kapoor, N
